Pufang Biopharma

普方生物

Pufang Biopharma

Biotech/Healthcare

ProfoundBio uses a platform-based R&D approach to deliver tumor-targeted therapies and develop innovative targeted drugs, with the goal of widening the therapeutic window and improving outcomes for cancer patients. Its pipeline consists of novel targeted drug candidates focused on areas of high…

Latest round: Series A Extension (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-06-01